The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Full Deal Summary

Hildred Capital Partners' portfolio company Crown Laboratories Inc. acquired North American distribution rights to five OTC consumer healthcare brands from GlaxoSmithKline PLC.

The products include PanOxyl, a daily acne wash; Sarna, an anti-itch lotion; Zeasorb, an anti-fungal and prevention product; Desenex, an anti-fungal powder for athlete's foot; and Mineral Ice, a pain-relieving gel. PanOxyl, Sarna, and Zeasorb were previously owned by Stiefel Labs and are well known brands in the dermatology and skin care space. Crown Labs is a global skin care company providing a wide range of beauty, consumer, prescription, medical and aesthetic products as well as pharmaceutical development and contract manufacturing. The company has been acquisitive and recently bought the first FDA-cleared medical grade microneedling device, SkinPen.


+ Show All | – Hide All

Financials

There are no financials available.

Deal Information


Click a keyword for comparable deals.

Deal Industry Pharmaceuticals
OTC, Consumer
Deal Status Final
Deal Type Alliance
Reverse Licensing
Marketing-Licensing
Latest Phase at Time of Deal Marketing
Marketed

Product Information


Click a keyword for comparable deals.

Product 1 of 5
Product Type Pharmaceutical
Generic Name Benzoyl peroxide
Brand Name PanOxyl
Highest Phase at Time of Deal Marketing
Marketed
Product Therapeutic Area(s) of Focus Dermatology
Acne
Licenser Name GlaxoSmithKline PLC
Licensee Name Crown Laboratories Inc.
Carveouts for Crown Laboratories Inc.
Territories Licensed Worldwide
Worldwide/North America (All) (Exclusive)

Product 2 of 5
Product Type Pharmaceutical
Generic Name Camphor/menthol/phenol
Brand Name Sarna
Highest Phase at Time of Deal Marketing
Marketed
Product Therapeutic Area(s) of Focus Dermatology
Itching
Licenser Name GlaxoSmithKline PLC
Licensee Name Crown Laboratories Inc.
Carveouts for Crown Laboratories Inc.
Territories Licensed Worldwide
Worldwide/North America (All) (Exclusive)

Product 3 of 5
Product Type Pharmaceutical
Generic Name Miconazole nitrate
Brand Name Zeasorb
Mechanism of Action Lanosterol 14 Alpha-Demethylase (CYP51) Inhibitor
Highest Phase at Time of Deal Marketing
Marketed
Product Therapeutic Area(s) of Focus Infectious & Viral Diseases
Antifungal
Licenser Name GlaxoSmithKline PLC
Licensee Name Crown Laboratories Inc.
Carveouts for Crown Laboratories Inc.
Territories Licensed Worldwide
Worldwide/North America (All) (Exclusive)

Product 4 of 5
Product Type Pharmaceutical
Generic Name Miconazole nitrate
Brand Name Desenex
Mechanism of Action Lanosterol 14 Alpha-Demethylase (CYP51) Inhibitor
Highest Phase at Time of Deal Marketing
Marketed
Product Therapeutic Area(s) of Focus Infectious & Viral Diseases
Antifungal
Athlete's Foot
Licenser Name GlaxoSmithKline PLC
Licensee Name Crown Laboratories Inc.
Carveouts for Crown Laboratories Inc.
Territories Licensed Worldwide
Worldwide/North America (All) (Exclusive)

Product 5 of 5
Product Type Pharmaceutical
Generic Name Menthol
Brand Name Mineral Ice
Mechanism of Action TRPM8 Opener
Highest Phase at Time of Deal Marketing
Marketed
Product Therapeutic Area(s) of Focus Neurology, Nervous System
Pain
Licenser Name GlaxoSmithKline PLC
Licensee Name Crown Laboratories Inc.
Carveouts for Crown Laboratories Inc.
Territories Licensed Worldwide
Worldwide/North America (All) (Exclusive)

Company Information


Click a keyword for comparable companies.

Crown Laboratories Inc. crownlaboratories.com
View Company Profile | View Company Deals
Company Location Worldwide
North America
USA
TN
Industry Contract Research, Toxicology Testing-CRO
Pharmaceuticals
Nutraceuticals
OTC, Consumer
Ownership Private

GlaxoSmithKline PLC www.gsk.com | Ticker: GSK
View Company Profile | View Company Deals
Company Location Worldwide
Europe
Western Europe
UK
Industry Pharmaceuticals
Vaccines
Description Big Pharma
Ownership Public
Therapeutic Area(s) of Focus Cancer
Cardiovascular
Dermatology
Immune Disorders
Infectious & Viral Diseases
Inflammation
Metabolic Disorders
Neurology, Nervous System
Ophthalmic
Respiratory, Pulmonary
Company Advisors (Underwriters) Crosstree Capital Partners